secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lucid Diagnostics Inc. (LUCD)
CIK:        0001799011
Form:       8-K
Filed at:   2022-12-02T23:59:59+00:00
Accession:  0001493152-22-034355
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lucid Diagnostics issues 3.38M shares to parent PAVmed for services, expense reimbursement, and acquisition
--------------------------------------------------------------------------------

- PAVmed elected stock for $1.65M in MSA fees (July-Sept 2022): 750,818 shares at 0.70 floor.
- New PBERA formalizes expense reimbursement; PAVmed received 1,479,326 shares for $2.72M in accrued payroll/benefits.
- CapNostics assignment settled with 1,145,086 shares to PAVmed, covering the ~$2.1M purchase price.
- Total issuance of 3,375,230 unregistered shares to parent under Section 4(a)(2) exemptions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799011/000149315222034355/0001493152-22-034355-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799011/000149315222034355/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-034355

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer